Trials / Withdrawn
WithdrawnNCT05748392
3M Veraflo™ Cleanse Choice Complete™ (VFCCC) Clinical Study
A Post-market, Multicenter, Prospective, Single-arm Study Evaluating Safety and Performance of the Veraflo™ Cleanse Choice Complete™ Dressing
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Solventum US LLC · Industry
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this external clinical study is to demonstrate the safety and performance of the Veraflo™ Cleanse Choice Complete™ Dressing Kit which will be used in conjunction with the V.A.C.® Ulta™ Therapy Unit, utilizing V.A.C. Veraflo™ Therapy instillation functions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Wound and per-wound assessments While using Device | 3D imaging and wound and per-wound skin characteristics will be conducted initially, at dressing changes and at end of treatment/study. |
Timeline
- Start date
- 2023-06-01
- Primary completion
- 2023-06-01
- Completion
- 2023-06-01
- First posted
- 2023-02-28
- Last updated
- 2024-10-01
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05748392. Inclusion in this directory is not an endorsement.